Prevalence of metabolic syndrome in adults with excess of adiposity:: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition

被引：17
作者：
Gonzalez-Ortiz, M. [1 ]
Martinez-Abundis, E. [1 ]
Jacques-Camarena, O. [1 ]
Hernandez-Gonzalez, S. O. [1 ]
Valera-Gonzalez, I. G. [1 ]
Ramos-Zavala, M. G. [1 ]
机构：
[1] Mexican Inst Social Secur, W Natl Med Ctr, Med Unit High Specialty, Med Res Unit Clin Epidemiol Hosp Specialties, Guadalajara, Jalisco, Mexico
来源：
ACTA DIABETOLOGICA | 2006年 / 43卷 / 03期
关键词：
adiposity; metabolic syndrome; ATP III; IDF;
D O I：
10.1007/s00592-006-0218-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim was to compare the Adult Treatment Panel (ATP) III criteria with the International Diabetes Federation (IDF) definition of metabolic syndrome (MS) in adults with excess adiposity who were considered a high-risk population. A cross-sectional study was carried out in 274 adults with excess adiposity. MS was assessed in all volunteers considering the ATP III criteria and the new IDF definition. Among all individuals, 130 (47%) were similarly classified under the two definitions. Under the ATP III criteria, but not the IDF definition, 2 (1%) participants had MS, and 29 (11%) subjects had MS under the IDF definition but not the ATP III criteria (p=0.009). The ATP III criteria and the IDF definition were useful for identifying MS in adults with excess of adiposity; however, the IDF proposal identified a greater percentage of patients.
引用
收藏
页码：84 / 86
页数：3
相关论文
共 14 条
  • [1] High prevalence of metabolic syndrome in Mexico
    Aguilar-Salinas, CA
    Rojas, R
    Gómez-Pérez, FJ
    Valles, V
    Ríos-Torres, JM
    Franco, A
    Olaiz, G
    Rull, JA
    Sepúlveda, J
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2004, 35 (01) : 76 - 81
  • [2] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [3] 2-S
  • [4] Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease
    Alessi, MC
    Peiretti, F
    Morange, P
    Henry, M
    Nalbone, G
    JuhanVague, I
    [J]. DIABETES, 1997, 46 (05) : 860 - 867
  • [5] Bertin E, 2000, DIABETES METAB, V26, P178
  • [6] Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome
    Carr, DB
    Utzschneider, KM
    Hull, RL
    Kodama, K
    Retzlaff, BM
    Brunzell, JD
    Shofer, JB
    Fish, BE
    Knopp, RH
    Kahn, SE
    [J]. DIABETES, 2004, 53 (08) : 2087 - 2094
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S
    Ford, ES
    [J]. DIABETES CARE, 2005, 28 (11) : 2745 - 2749
  • [9] International Diabetes Federation, 2005, 1 INT C PRED MET SYN
  • [10] Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus
    Katsuki, A
    Sumida, Y
    Murashima, S
    Murata, K
    Takarada, Y
    Ito, K
    Fujii, M
    Tsuchihashi, K
    Goto, H
    Nakatani, K
    Yano, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 859 - 862
12